Related Experiment Videos

Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy

D J Loskutoff¹

¹Research Institute of Scripps Clinic, Immunology Department, La Jolla, CA 92037.

Seminars in Thrombosis and Hemostasis

|January 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Plasminogen activator inhibitors.

Trends in cardiovascular medicine·2011

The regulation of uterine tissue factor by estrogen.

Endocrine·2010

Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.

Journal of thrombosis and haemostasis : JTH·2006

Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.

Journal of thrombosis and haemostasis : JTH·2005

Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress: a possible mechanism of stress-induced renal fibrin deposition in obese mice.

Journal of thrombosis and haemostasis : JTH·2005

The leptin receptor system of human platelets.

Journal of thrombosis and haemostasis : JTH·2005

See all related articles